News Items

19 Mar 2009

SDP Technology and Alchemia Enter Cancer Drug Collaboration

Australian drug developer, SDP Technology Limited has entered into a drug discovery agreement with Alchemia Limited (ASX:ACL). SDP will have exclusive rights to develop anti-cancer drugs targeting the enzyme sphingosine kinase 1 (SK1) using Alchemia’s VAST chemistry. More

10 Feb 2009

Nature Biotechnology Volume 27 Number 1

Four steps to finding the right people. Of all the ingredients in a biotech start-up, getting the right people involved is most crucial. Here, Ian Brown, CEO of SDP Technology, provides pointers for putting together a successful business team. More

01 Dec 2008

Dr Steve Rietiker joins SDP Board of Directors

SDP is pleased to announce that Dr Steve Rietiker has joined SDP Board of Directors as a Non Executive Director. More

28 Jul 2008

Professor Mathew Vadas joins SDP as Scientific and Therapeutic Adviser

SDP is pleased to announce that Professor Mathew Vadas has joined SDP as Scientific and Therapeutic Adviser. More

22 Apr 2008

SDP Presents at SACHS European CEO Forum

SDP Managing Director & CEO Presents at SACHS European Life Science CEO Forum More

26 Mar 2008

SDP Awarded Commercial Ready Plus Grant

SDP has been awarded a $236,000 Commercial Ready Plus Grant More

27 Nov 2007

SDP Receives Government Grant

SDP is pleased to announce that it has received a City of Melbourne Small Business Grant. More

20 Aug 2007

SDP Appoints New Chairman

SDP is pleased to announce that Mr Andrew Lord has joined SDP as the New Chairman. More

30 Jul 2007

SDP Appoints New Managing Director & CEO

SDP is pleased to announce that Mr Ian Brown has joined SDP as the New Managing Director & CEO. More